TLR3 and head and neck carcinoma: We therefore decided to assess the impact of TLR3 stimulation on the metabolic profile of the 4 head and neck carcinoma cell lines HONE1, FaDU, CNE1 and SQ20B cells using a metabolomics approach targeted on glucose metabolism pathways.